BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35724560)

  • 1. Short-term outcome for high-risk patients after esophagectomy.
    Plat VD; Stam WT; Bootsma BT; Straatman J; Klausch T; Heineman DJ; van der Peet DL; Daams F;
    Dis Esophagus; 2022 Dec; 36(1):. PubMed ID: 35724560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transthoracic Versus Transhiatal Esophagectomy for Esophageal Cancer: A Nationwide Propensity Score-Matched Cohort Analysis.
    Mertens AC; Kalff MC; Eshuis WJ; Van Gulik TM; Van Berge Henegouwen MI; Gisbertz SS;
    Ann Surg Oncol; 2021 Jan; 28(1):175-183. PubMed ID: 32607607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term outcomes of robotic radical esophagectomy for esophageal cancer by a nontransthoracic approach compared with conventional transthoracic surgery.
    Mori K; Yamagata Y; Aikou S; Nishida M; Kiyokawa T; Yagi K; Yamashita H; Nomura S; Seto Y
    Dis Esophagus; 2016 Jul; 29(5):429-34. PubMed ID: 25809390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-based selective application of transhiatal esophagectomy in a high-volume esophageal center.
    Donohoe CL; O'Farrell NJ; Ravi N; Reynolds JV
    World J Surg; 2012 Jan; 36(1):98-103. PubMed ID: 21979584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Paratracheal Lymphadenectomy on Lymph Node Yield and Short-Term Outcomes in Esophagectomy for Cancer: A Nation-Wide Propensity Score-Matched Analysis.
    Kingma BF; Hagens ERC; Van Berge Henegouwen MI; Borggreve AS; Ruurda JP; Gisbertz SS; van Hillegersberg R
    Dig Surg; 2023; 40(1-2):58-68. PubMed ID: 36882004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age and Charlson Comorbidity Index score are not independent risk factors for severe complications after curative esophagectomy for esophageal cancer: a Dutch population-based cohort study.
    Baranov N; Claassen L; van Workum F; Rosman C
    Surg Oncol; 2022 Aug; 43():101789. PubMed ID: 35792370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transhiatal vs. Transthoracic Esophagectomy: A NSQIP Analysis of Postoperative Outcomes and Risk Factors for Morbidity.
    Schlottmann F; Strassle PD; Patti MG
    J Gastrointest Surg; 2017 Nov; 21(11):1757-1763. PubMed ID: 28900830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Survival After Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Nationwide Propensity-score Matched Analysis.
    Kalff MC; Fransen LFC; de Groot EM; Gisbertz SS; Nieuwenhuijzen GAP; Ruurda JP; Verhoeven RHA; Luyer MDP; van Hillegersberg R; van Berge Henegouwen MI;
    Ann Surg; 2022 Dec; 276(6):e749-e757. PubMed ID: 33378310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of short-term outcomes between 2- and 3-field lymph node dissection for esophageal cancer.
    Yamashita K; Makino T; Yamasaki M; Tanaka K; Hara T; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
    Dis Esophagus; 2017 Nov; 30(11):1-8. PubMed ID: 28881906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What should be the gold standard for the surgical component in the treatment of locally advanced esophageal cancer: transthoracic versus transhiatal esophagectomy.
    Kutup A; Nentwich MF; Bollschweiler E; Bogoevski D; Izbicki JR; Hölscher AH
    Ann Surg; 2014 Dec; 260(6):1016-22. PubMed ID: 24950288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer, a randomized controlled trial (ROBOT trial).
    van der Sluis PC; Ruurda JP; van der Horst S; Verhage RJ; Besselink MG; Prins MJ; Haverkamp L; Schippers C; Rinkes IH; Joore HC; Ten Kate FJ; Koffijberg H; Kroese CC; van Leeuwen MS; Lolkema MP; Reerink O; Schipper ME; Steenhagen E; Vleggaar FP; Voest EE; Siersema PD; van Hillegersberg R
    Trials; 2012 Nov; 13():230. PubMed ID: 23199187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative complications after a transthoracic esophagectomy or a transhiatal gastrectomy in patients with esophagogastric junctional cancers: a prospective nationwide multicenter study.
    Mine S; Kurokawa Y; Takeuchi H; Terashima M; Yasuda T; Yoshida K; Yabusaki H; Shirakawa Y; Fujitani K; Sano T; Doki Y; Kitagawa Y
    Gastric Cancer; 2022 Mar; 25(2):430-437. PubMed ID: 34590178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Propensity Score Matched Analysis of Open Versus Minimally Invasive Transthoracic Esophagectomy in the Netherlands.
    Seesing MFJ; Gisbertz SS; Goense L; van Hillegersberg R; Kroon HM; Lagarde SM; Ruurda JP; Slaman AE; van Berge Henegouwen MI; Wijnhoven BPL
    Ann Surg; 2017 Nov; 266(5):839-846. PubMed ID: 28796016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Favourable long-term survival of patients with esophageal cancer treated with extended transhiatal esophagectomy combined with en bloc lymphadenectomy: results from a retrospective observational cohort study.
    Kröll D; Borbély YM; Dislich B; Haltmeier T; Malinka T; Biebl M; Langer R; Candinas D; Seiler C
    BMC Surg; 2020 Sep; 20(1):197. PubMed ID: 32917177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thoracoscopy-Assisted Esophagectomy vs Transhiatal Esophagectomy for Carcinoma Esophagus: a Prospective Comparison of Short-Term Outcomes.
    Deo KB; Singh H; Gupta V; Das A; Verma GR; Gupta R
    J Gastrointest Cancer; 2022 Jun; 53(2):333-340. PubMed ID: 33629171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Population-based Study on Lymph Node Retrieval in Patients with Esophageal Cancer: Results from the Dutch Upper Gastrointestinal Cancer Audit.
    van der Werf LR; Dikken JL; van Berge Henegouwen MI; Lemmens VEPP; Nieuwenhuijzen GAP; Wijnhoven BPL;
    Ann Surg Oncol; 2018 May; 25(5):1211-1220. PubMed ID: 29524046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical advantage of transmediastinal esophagectomy in terms of postoperative respiratory complications.
    Ogawa K; Akashi Y; Hisakura K; Kim J; Owada Y; Ohara Y; Enomoto T; Furuya K; Moue S; Miyazaki Y; Doi M; Shimomura O; Takahashi K; Hashimoto S; Oda T
    Int J Clin Oncol; 2023 Jun; 28(6):748-755. PubMed ID: 36928515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transhiatal versus transthoracic esophagectomy for esophageal SCC: outcomes and complications.
    Soltani E; Mahmoodzadeh H; Jabbari Nooghabi A; Jabbari Nooghabi M; Ravankhah Moghaddam K; Hassanzadeh Haddad E
    J Cardiothorac Surg; 2022 Jun; 17(1):150. PubMed ID: 35681156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited Lymph Node Resection Does Not Decrease Postoperative Mortality After Esophagectomy in Octogenarians With Thoracic Esophageal Cancer.
    Li Q; Zhu S; Liu S; Zhang G; Li X
    J Surg Res; 2021 Mar; 259():538-545. PubMed ID: 33162102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II.
    Leers JM; Knepper L; van der Veen A; Schröder W; Fuchs H; Schiller P; Hellmich M; Zettelmeyer U; Brosens LAA; Quaas A; Ruurda JP; van Hillegersberg R; Bruns CJ
    BMC Cancer; 2020 Aug; 20(1):781. PubMed ID: 32819399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.